Eniva Nutraceutics

Jan 15, 2015

Achieving the Next Growth Phase

Eniva Nutraceutics has worked with B2BCFO and Kate Sterner for the past year. Our company specializes in the development, manufacture and distribution of pharmaceutical-grade health supplements ("nutraceuticals"). At the time of engagement, our business model was in transition. We had made the strategic decision to expand distribution of our innovative health products into new markets--including new B2B arenas, the medical marketplace and a sophisticated new e-commerce platform. Additionally, our accounting system was in need of updating to integrate with the list of e-commerce vendors that would be supporting the new platform. 

I am excited to report as a result of our B2B expert working with internal staff, we will shortly "go live" with a new, robust commerce platform linking web-based order entry/inventory management to Avalara tax reporting and Quickbooks Enterprise for financial reporting. This fully integrated system will reduce current manual processes by 80% and provide automation for bank reconciliation and fulfillment activities. 

Additionally, as a result of our B2B experience, we've already been able to achieve closing our books within 10 days of month end - providing meaningful data to assist in strategic decision making, freeing up time to focus on FDA certifications of our facility and allowing focus on the international re-launch of the Eniva brand. 

At Eniva, our motto is "Wellness to the World". With the outstanding guidance of B2B at our side, I am confident Eniva's new initiatives and innovative health products will help millions of people around the globe improve their health outcomes. 

For those considering an engagement with B2B, I give their organization, and Kate Sterner, my highest recommendation. 

Andrew J. Baechler, CEO

http://www.enivanutraceutics.com/  

Eniva Nutraceutics Corporation 

2700 Campus Drive Plymouth, MN 55441

 763-795-8870

Books


A collection of books from B2B CFO® to help any business succeed. Read the first chapter from books, including the Wall Street Journal’s book, for free.